Processa Pharmaceuticals, Inc. (PCSA) Current Reports & Earnings Releases
| Filed | Form | Items | Filing |
|---|---|---|---|
| 2026-08-04 | 8-K | Officer / Director Changes, Shareholder Vote Results, Financial Statements & Exhibits | SEC |
| 2026-07-29 | 8-K | Material Agreement, Termination of Agreement, Acquisition or Disposition, Unregistered Sales, Officer / Director Changes, Charter Amendments, Reg FD Disclosure, Financial Statements & Exhibits | SEC |
| 2026-04-30 | 8-K | Officer / Director Changes, Financial Statements & Exhibits | SEC |
| 2026-02-19 | 8-K | Termination of Agreement, Financial Statements & Exhibits | SEC |
| 2026-01-07 | 8-K | Other Events, Financial Statements & Exhibits | SEC |
| 2025-12-15 | 8-K | Item 3.03, Charter Amendments, Financial Statements & Exhibits | SEC |
| 2025-09-12 | 8-K | Shareholder Vote Results, Financial Statements & Exhibits | SEC |
| 2025-09-10 | 8-K | Shareholder Vote Results | SEC |
| 2025-09-02 | 8-K | Shareholder Vote Results | SEC |
| 2025-08-25 | 8-K | Other Events, Financial Statements & Exhibits | SEC |
| 2025-08-08 | 8-K | Listing Notice, Financial Statements & Exhibits | SEC |
| 2025-08-07 | 8-K | Material Agreement, Unregistered Sales, Reg FD Disclosure, Financial Statements & Exhibits | SEC |
| 2025-07-25 | 8-K | Other Events, Financial Statements & Exhibits | SEC |
| 2025-07-18 | 8-K | Shareholder Vote Results, Financial Statements & Exhibits | SEC |
| 2025-07-15 | 8-K | Shareholder Vote Results | SEC |
| 2025-07-01 | 8-K | Material Agreement, Reg FD Disclosure, Financial Statements & Exhibits | SEC |
| 2025-06-30 | 8-K | Material Agreement, Shareholder Vote Results, Financial Statements & Exhibits | SEC |
| 2025-06-18 | 8-K | Material Agreement, Reg FD Disclosure, Financial Statements & Exhibits | SEC |
| 2025-06-17 | 8-K | Material Agreement, Reg FD Disclosure, Financial Statements & Exhibits | SEC |
| 2025-02-11 | 8-K | Reg FD Disclosure, Financial Statements & Exhibits | SEC |
| 2025-02-10 | 8-K | Listing Notice | SEC |
| 2025-01-30 | 8-K | Material Agreement, Reg FD Disclosure, Financial Statements & Exhibits | SEC |
| 2024-11-06 | 8-K | Auditor Change, Financial Statements & Exhibits | SEC |
| 2024-10-02 | 8-K | Other Events, Financial Statements & Exhibits | SEC |
| 2024-08-28 | 8-K | Other Events, Financial Statements & Exhibits | SEC |
| 2024-07-30 | 8-K | Other Events, Financial Statements & Exhibits | SEC |
| 2024-07-17 | 8-K | Officer / Director Changes, Reg FD Disclosure, Financial Statements & Exhibits | SEC |
| 2024-07-02 | 8-K | Shareholder Vote Results, Financial Statements & Exhibits | SEC |
| 2024-05-21 | 8-K | Material Agreement, Financial Statements & Exhibits | SEC |
| 2024-04-11 | 8-K | Reg FD Disclosure, Financial Statements & Exhibits | SEC |
| 2024-04-04 | 8-K | Reg FD Disclosure, Financial Statements & Exhibits | SEC |
| 2024-02-21 | 8-K | Reg FD Disclosure, Financial Statements & Exhibits | SEC |
| 2024-02-06 | 8-K | Other Events, Financial Statements & Exhibits | SEC |
| 2024-01-30 | 8-K | Material Agreement, Reg FD Disclosure, Financial Statements & Exhibits | SEC |
| 2024-01-25 | 8-K | Other Events, Financial Statements & Exhibits | SEC |
| 2024-01-19 | 8-K | Reg FD Disclosure, Financial Statements & Exhibits | SEC |
| 2024-01-18 | 8-K | Item 3.03, Charter Amendments, Financial Statements & Exhibits | SEC |
| 2024-01-08 | 8-K | Reg FD Disclosure, Financial Statements & Exhibits | SEC |
Sourced from SEC EDGAR 8-K/6-K filings. 8-K is the current-report form for US domestic issuers (Item 2.02 = earnings release); 6-K is the equivalent for foreign private issuers, including ADRs. Originals live on sec.gov.